These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 11796104)

  • 1. Phosphoserine-dependent regulation of protein-protein interactions in the Smad pathway.
    Wrana JL
    Structure; 2002 Jan; 10(1):5-7. PubMed ID: 11796104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structure of a phosphorylated Smad2. Recognition of phosphoserine by the MH2 domain and insights on Smad function in TGF-beta signaling.
    Wu JW; Hu M; Chai J; Seoane J; Huse M; Li C; Rigotti DJ; Kyin S; Muir TW; Fairman R; Massagué J; Shi Y
    Mol Cell; 2001 Dec; 8(6):1277-89. PubMed ID: 11779503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The FYVE domain in Smad anchor for receptor activation (SARA) is sufficient for localization of SARA in early endosomes and regulates TGF-beta/Smad signalling.
    Itoh F; Divecha N; Brocks L; Oomen L; Janssen H; Calafat J; Itoh S; Dijke Pt Pt
    Genes Cells; 2002 Mar; 7(3):321-31. PubMed ID: 11918675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The transcriptional co-activator P/CAF potentiates TGF-beta/Smad signaling.
    Itoh S; Ericsson J; Nishikawa J; Heldin CH; ten Dijke P
    Nucleic Acids Res; 2000 Nov; 28(21):4291-8. PubMed ID: 11058129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Smad-dependent and Smad-independent pathways in TGF-beta family signalling.
    Derynck R; Zhang YE
    Nature; 2003 Oct; 425(6958):577-84. PubMed ID: 14534577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional conservation of Schistosoma mansoni Smads in TGF-beta signaling.
    Beall MJ; McGonigle S; Pearce EJ
    Mol Biochem Parasitol; 2000 Nov; 111(1):131-42. PubMed ID: 11087923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The TGF beta receptor activation process: an inhibitor- to substrate-binding switch.
    Huse M; Muir TW; Xu L; Chen YG; Kuriyan J; Massagué J
    Mol Cell; 2001 Sep; 8(3):671-82. PubMed ID: 11583628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis of heteromeric smad protein assembly in TGF-beta signaling.
    Chacko BM; Qin BY; Tiwari A; Shi G; Lam S; Hayward LJ; De Caestecker M; Lin K
    Mol Cell; 2004 Sep; 15(5):813-23. PubMed ID: 15350224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SMADs: mediators and regulators of TGF-beta signaling.
    Kretzschmar M; Massagué J
    Curr Opin Genet Dev; 1998 Feb; 8(1):103-11. PubMed ID: 9529613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor-β signalling: role and consequences of Smad linker region phosphorylation.
    Kamato D; Burch ML; Piva TJ; Rezaei HB; Rostam MA; Xu S; Zheng W; Little PJ; Osman N
    Cell Signal; 2013 Oct; 25(10):2017-24. PubMed ID: 23770288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SPARC inhibits epithelial cell proliferation in part through stimulation of the transforming growth factor-beta-signaling system.
    Schiemann BJ; Neil JR; Schiemann WP
    Mol Biol Cell; 2003 Oct; 14(10):3977-88. PubMed ID: 14517312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Smads "freeze" when they ski.
    Frederick JP; Wang XF
    Structure; 2002 Dec; 10(12):1607-11. PubMed ID: 12467567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Smad signalling network.
    Moustakas A
    J Cell Sci; 2002 Sep; 115(Pt 17):3355-6. PubMed ID: 12154066
    [No Abstract]   [Full Text] [Related]  

  • 14. The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells.
    Poncelet AC; de Caestecker MP; Schnaper HW
    Kidney Int; 1999 Oct; 56(4):1354-65. PubMed ID: 10504488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Semisynthesis of phosphovariants of Smad2 reveals a substrate preference of the activated T beta RI kinase.
    Ottesen JJ; Huse M; Sekedat MD; Muir TW
    Biochemistry; 2004 May; 43(19):5698-706. PubMed ID: 15134444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SPARC regulates TGF-beta1-dependent signaling in primary glomerular mesangial cells.
    Francki A; McClure TD; Brekken RA; Motamed K; Murri C; Wang T; Sage EH
    J Cell Biochem; 2004 Apr; 91(5):915-25. PubMed ID: 15034927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclic adenosine 3',5'-monophosphate-elevating agents inhibit transforming growth factor-beta-induced SMAD3/4-dependent transcription via a protein kinase A-dependent mechanism.
    Schiller M; Verrecchia F; Mauviel A
    Oncogene; 2003 Dec; 22(55):8881-90. PubMed ID: 14654784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of Smad signalling by protein associations and signalling crosstalk.
    Zhang Y; Derynck R
    Trends Cell Biol; 1999 Jul; 9(7):274-9. PubMed ID: 10370243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TLP, a novel modulator of TGF-beta signaling, has opposite effects on Smad2- and Smad3-dependent signaling.
    Felici A; Wurthner JU; Parks WT; Giam LR; Reiss M; Karpova TS; McNally JG; Roberts AB
    EMBO J; 2003 Sep; 22(17):4465-77. PubMed ID: 12941698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The N domain of Smad7 is essential for specific inhibition of transforming growth factor-beta signaling.
    Hanyu A; Ishidou Y; Ebisawa T; Shimanuki T; Imamura T; Miyazono K
    J Cell Biol; 2001 Dec; 155(6):1017-27. PubMed ID: 11739411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.